The truth is not dead, but it’s on life support,” says Simon Schama. He points to how basic facts such as the theory of ...
"Joining Gannet BioChem marks an exciting next chapter for our team and our customers,” said Jon McKannan, President of ...
Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...
Agilent Technologies, Inc. (A), headquartered in Santa Clara, California, provides application focused solutions to the life ...
Naveen Tewari, founder and CEO of InMobi Group, pioneers mobile marketing and advertising globally. He also leads Glance, a ...
The biopharmaceutical company said Wednesday it held a scheduled BPD Type 2a meeting, which is meant to focus specifically on a narrow set of issues. The meeting aimed to review AEON's analytical ...
The Fine and Specialty Chemicals Market is entering a transformative phase of high-value innovation and application-specific customization, underpinned by specialty chemicals’ critical role as ...
For companies developing interchangeable biosimilars, the FDA guidance opens the door to more tailored, risk-based programs that may reduce reliance on costly comparative efficacy studies (CES). For ...
A deep learning framework combines convolutional and bidirectional recurrent networks to improve protein function prediction from genomic sequences. By automating feature extraction and capturing long ...
This absence of interiority can be described as a deficit, as if something essential were missing. But another way to see it ...
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
Key market opportunities include rising demand for bioanalytical testing due to increased drug development, prevalence of chronic diseases, and biologics expansion. Advanced technologies and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results